CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Indinavir sulfate +7 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000922
NCT00000922N/ACompleted
CompareCT.gov

A Randomized, Open-Label Study of the Long-Term Effectiveness of Three Initial Highly Active Antiretroviral Therapy (HAART) Strategies in HAART-Niave, HIV-Infected Persons

National Institute of Allergy and Infectious Diseases (NIAID)·interventional·Posted Aug 31, 2001·Updated Apr 17, 2014

In Brief

A clinical study evaluating Indinavir sulfate, Abacavir sulfate, and 6 other interventions for HIV Infections. Completed, across 17 sites.

Detailed Summary

The purpose of this study is to determine whether it is better to start an anti-HIV regimen containing a protease inhibitor (PI), a non-nucleoside reverse transcriptase inhibitor (NNRTI), or a PI in combination with an NNRTI. This study will also examine which treatment regimen is best as a first treatment for HIV infection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 31, 2001
Primary CompletionJan 1, 2003
Study CompletionJun 1, 2006
TodayJul 2, 2026
Posted 24.8 years ago

Interventions

Indinavir sulfatedrug

Abacavir sulfatedrug

Nelfinavir mesylatedrug

Efavirenzdrug

Nevirapinedrug

Lamivudinedrug

Stavudinedrug

Didanosinedrug